Report Detail
Global Mammalian Cell Banking Market Research Report 2022
- RnM4440800 |
- 17 May, 2022 |
- Global |
- 87 Pages |
- QYResearch |
- Medical Devices & Consumables
Summary:
Mammalian Cells are regularly used in the biopharmaceutical industry for the production of recombinant therapeutic proteins. Moreover, mammalian cell lines are used as host cells for the production of biologics in the biopharmaceutical industry.
Industry Insights
The global Mammalian Cell Banking market size is projected to reach US$ million by 2028, from US$ million in 2021, at a CAGR of % during 2022-2028.
Fully considering the economic change by this health crisis, Master Cell Banks accounting for % of the Mammalian Cell Banking global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While Academic & Research Laboratories segment is altered to an % CAGR throughout this forecast period.
China Mammalian Cell Banking market size is valued at US$ million in 2021, while the North America and Europe Mammalian Cell Banking are US$ million and US$ million, severally. The proportion of the North America is % in 2021, while China and Europe are % and respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period 2022-2028. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period. As for the Europe Mammalian Cell Banking landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period 2022-2028.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Mammalian Cell Banking market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Mammalian Cell Banking market in terms of revenue.
Overall, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Mammalian Cell Banking market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Mammalian Cell Banking market.
Impact of Covid-19 Outbreak
This section of the report has explored the overall status of the Covid scenario and has offered valuable insights into the changes in supply chain disruption, fluctuations in demand, etc. The analysts have also focused on the key measures that the companies are opting to withstand the harsh scenario.
Segmental Analysis
The report has been segmented into product and application segments. The researchers have documented all the products present today in the Mammalian Cell Banking market. They have also shed light on the new product innovations and launches by the key players. In the segmental analysis, the analysts have provided revenue forecast figures based on type and application for the period 2017-2028. They have also discussed about the growth rate and potential of each segment for the period 2017-2028.
Mammalian Cell Banking Breakdown Data by Type
Master Cell Banks
Working Cell Banks
End of Production Cell Banks
Research & Development Cell Banks
Others
Mammalian Cell Banking Breakdown Data by Application
Academic & Research Laboratories
Biopharmaceutical Companies
Contract Research Organizations (CROs)
Others
Regional Analysis
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Competitive Landscape
This segment focuses on the key players operating in the industry. It underlines all the current and future activities by the prominent manufacturers. By understanding various initiatives being taken up by different players, readers will gain the ability to settle on correct business choices. The authors of the report have provided accurate revenue figures of the companies for the period 2017-2022. The clients are sure to gain the upper hand once they get hold of this report. Key players studied in the research report include:
Sartorius Stedim BioOutsource Limited.
Charles River Laboratories.
Eurofins DiscoverX Corporation
Merck KGaA
Lonza Group Ltd
VIRUSURE
Altogen Labs
Abzena Ltd
Northway Biotechpharma
Selexis SA
Frequently Asked Questions
What factors will challenge the Mammalian Cell Banking market growth?
Which end-use segment will expand at the fastest CAGR in the Mammalian Cell Banking market?
Which are the emerging players in the Mammalian Cell Banking market?
How concentrated is the Mammalian Cell Banking market?
Which factors are positively contributing to the Mammalian Cell Banking market growth?
Which are the novel product innovations in the Mammalian Cell Banking market?
Which product segment will emerge as the most lucrative in the Mammalian Cell Banking market?
Which factors are increasing the competition in the Mammalian Cell Banking market?
Which are the strategic measures taken by the Mammalian Cell Banking industry players?
Which region will witness inactive growth during the forecast period?
What key trends are likely to emerge in the Mammalian Cell Banking market in the coming years?
Table of Contents
1 Report Overview
- 1.1 Study Scope
- 1.2 Market Analysis by Type
- 1.2.1 Global Mammalian Cell Banking Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
- 1.2.2 Master Cell Banks
- 1.2.3 Working Cell Banks
- 1.2.4 End of Production Cell Banks
- 1.2.5 Research & Development Cell Banks
- 1.2.6 Others
- 1.3 Market by Application
- 1.3.1 Global Mammalian Cell Banking Market Share by Application: 2017 VS 2021 VS 2028
- 1.3.2 Academic & Research Laboratories
- 1.3.3 Biopharmaceutical Companies
- 1.3.4 Contract Research Organizations (CROs)
- 1.3.5 Others
- 1.4 Study Objectives
- 1.5 Years Considered
2 Global Growth Trends
- 2.1 Global Mammalian Cell Banking Market Perspective (2017-2028)
- 2.2 Mammalian Cell Banking Growth Trends by Region
- 2.2.1 Mammalian Cell Banking Market Size by Region: 2017 VS 2021 VS 2028
- 2.2.2 Mammalian Cell Banking Historic Market Size by Region (2017-2022)
- 2.2.3 Mammalian Cell Banking Forecasted Market Size by Region (2023-2028)
- 2.3 Mammalian Cell Banking Market Dynamics
- 2.3.1 Mammalian Cell Banking Industry Trends
- 2.3.2 Mammalian Cell Banking Market Drivers
- 2.3.3 Mammalian Cell Banking Market Challenges
- 2.3.4 Mammalian Cell Banking Market Restraints
3 Competition Landscape by Key Players
- 3.1 Global Top Mammalian Cell Banking Players by Revenue
- 3.1.1 Global Top Mammalian Cell Banking Players by Revenue (2017-2022)
- 3.1.2 Global Mammalian Cell Banking Revenue Market Share by Players (2017-2022)
- 3.2 Global Mammalian Cell Banking Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
- 3.3 Players Covered: Ranking by Mammalian Cell Banking Revenue
- 3.4 Global Mammalian Cell Banking Market Concentration Ratio
- 3.4.1 Global Mammalian Cell Banking Market Concentration Ratio (CR5 and HHI)
- 3.4.2 Global Top 10 and Top 5 Companies by Mammalian Cell Banking Revenue in 2021
- 3.5 Mammalian Cell Banking Key Players Head office and Area Served
- 3.6 Key Players Mammalian Cell Banking Product Solution and Service
- 3.7 Date of Enter into Mammalian Cell Banking Market
- 3.8 Mergers & Acquisitions, Expansion Plans
4 Mammalian Cell Banking Breakdown Data by Type
- 4.1 Global Mammalian Cell Banking Historic Market Size by Type (2017-2022)
- 4.2 Global Mammalian Cell Banking Forecasted Market Size by Type (2023-2028)
5 Mammalian Cell Banking Breakdown Data by Application
- 5.1 Global Mammalian Cell Banking Historic Market Size by Application (2017-2022)
- 5.2 Global Mammalian Cell Banking Forecasted Market Size by Application (2023-2028)
6 North America
- 6.1 North America Mammalian Cell Banking Market Size (2017-2028)
- 6.2 North America Mammalian Cell Banking Market Size by Country (2017-2022)
- 6.3 North America Mammalian Cell Banking Market Size by Country (2023-2028)
- 6.4 United States
- 6.5 Canada
7 Europe
- 7.1 Europe Mammalian Cell Banking Market Size (2017-2028)
- 7.2 Europe Mammalian Cell Banking Market Size by Country (2017-2022)
- 7.3 Europe Mammalian Cell Banking Market Size by Country (2023-2028)
- 7.4 Germany
- 7.5 France
- 7.6 U.K.
- 7.7 Italy
- 7.8 Russia
- 7.9 Nordic Countries
8 Asia-Pacific
- 8.1 Asia-Pacific Mammalian Cell Banking Market Size (2017-2028)
- 8.2 Asia-Pacific Mammalian Cell Banking Market Size by Country (2017-2022)
- 8.3 Asia-Pacific Mammalian Cell Banking Market Size by Country (2023-2028)
- 8.4 China
- 8.5 Japan
- 8.6 South Korea
- 8.7 Southeast Asia
- 8.8 India
- 8.9 Australia
9 Latin America
- 9.1 Latin America Mammalian Cell Banking Market Size (2017-2028)
- 9.2 Latin America Mammalian Cell Banking Market Size by Country (2017-2022)
- 9.3 Latin America Mammalian Cell Banking Market Size by Country (2023-2028)
- 9.4 Mexico
- 9.5 Brazil
10 Middle East & Africa
- 10.1 Middle East & Africa Mammalian Cell Banking Market Size (2017-2028)
- 10.2 Middle East & Africa Mammalian Cell Banking Market Size by Country (2017-2022)
- 10.3 Middle East & Africa Mammalian Cell Banking Market Size by Country (2023-2028)
- 10.4 Turkey
- 10.5 Saudi Arabia
- 10.6 UAE
11 Key Players Profiles
- 11.1 Sartorius Stedim BioOutsource Limited.
- 11.1.1 Sartorius Stedim BioOutsource Limited. Company Detail
- 11.1.2 Sartorius Stedim BioOutsource Limited. Business Overview
- 11.1.3 Sartorius Stedim BioOutsource Limited. Mammalian Cell Banking Introduction
- 11.1.4 Sartorius Stedim BioOutsource Limited. Revenue in Mammalian Cell Banking Business (2017-2022)
- 11.1.5 Sartorius Stedim BioOutsource Limited. Recent Development
- 11.2 Charles River Laboratories.
- 11.2.1 Charles River Laboratories. Company Detail
- 11.2.2 Charles River Laboratories. Business Overview
- 11.2.3 Charles River Laboratories. Mammalian Cell Banking Introduction
- 11.2.4 Charles River Laboratories. Revenue in Mammalian Cell Banking Business (2017-2022)
- 11.2.5 Charles River Laboratories. Recent Development
- 11.3 Eurofins DiscoverX Corporation
- 11.3.1 Eurofins DiscoverX Corporation Company Detail
- 11.3.2 Eurofins DiscoverX Corporation Business Overview
- 11.3.3 Eurofins DiscoverX Corporation Mammalian Cell Banking Introduction
- 11.3.4 Eurofins DiscoverX Corporation Revenue in Mammalian Cell Banking Business (2017-2022)
- 11.3.5 Eurofins DiscoverX Corporation Recent Development
- 11.4 Merck KGaA
- 11.4.1 Merck KGaA Company Detail
- 11.4.2 Merck KGaA Business Overview
- 11.4.3 Merck KGaA Mammalian Cell Banking Introduction
- 11.4.4 Merck KGaA Revenue in Mammalian Cell Banking Business (2017-2022)
- 11.4.5 Merck KGaA Recent Development
- 11.5 Lonza Group Ltd
- 11.5.1 Lonza Group Ltd Company Detail
- 11.5.2 Lonza Group Ltd Business Overview
- 11.5.3 Lonza Group Ltd Mammalian Cell Banking Introduction
- 11.5.4 Lonza Group Ltd Revenue in Mammalian Cell Banking Business (2017-2022)
- 11.5.5 Lonza Group Ltd Recent Development
- 11.6 VIRUSURE
- 11.6.1 VIRUSURE Company Detail
- 11.6.2 VIRUSURE Business Overview
- 11.6.3 VIRUSURE Mammalian Cell Banking Introduction
- 11.6.4 VIRUSURE Revenue in Mammalian Cell Banking Business (2017-2022)
- 11.6.5 VIRUSURE Recent Development
- 11.7 Altogen Labs
- 11.7.1 Altogen Labs Company Detail
- 11.7.2 Altogen Labs Business Overview
- 11.7.3 Altogen Labs Mammalian Cell Banking Introduction
- 11.7.4 Altogen Labs Revenue in Mammalian Cell Banking Business (2017-2022)
- 11.7.5 Altogen Labs Recent Development
- 11.8 Abzena Ltd
- 11.8.1 Abzena Ltd Company Detail
- 11.8.2 Abzena Ltd Business Overview
- 11.8.3 Abzena Ltd Mammalian Cell Banking Introduction
- 11.8.4 Abzena Ltd Revenue in Mammalian Cell Banking Business (2017-2022)
- 11.8.5 Abzena Ltd Recent Development
- 11.9 Northway Biotechpharma
- 11.9.1 Northway Biotechpharma Company Detail
- 11.9.2 Northway Biotechpharma Business Overview
- 11.9.3 Northway Biotechpharma Mammalian Cell Banking Introduction
- 11.9.4 Northway Biotechpharma Revenue in Mammalian Cell Banking Business (2017-2022)
- 11.9.5 Northway Biotechpharma Recent Development
- 11.10 Selexis SA
- 11.10.1 Selexis SA Company Detail
- 11.10.2 Selexis SA Business Overview
- 11.10.3 Selexis SA Mammalian Cell Banking Introduction
- 11.10.4 Selexis SA Revenue in Mammalian Cell Banking Business (2017-2022)
- 11.10.5 Selexis SA Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
- 13.1 Research Methodology
- 13.1.1 Methodology/Research Approach
- 13.1.2 Data Source
- 13.2 Disclaimer
Summary:
Get latest Market Research Reports on Mammalian Cell Banking. Industry analysis & Market Report on Mammalian Cell Banking is a syndicated market report, published as Global Mammalian Cell Banking Market Research Report 2022. It is complete Research Study and Industry Analysis of Mammalian Cell Banking market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
